Compounds for the control of hyperlipidemia using N-substituted

Details Compounds for the control of hyperlipidemia using N-substituted Compounds for the control of hyperlipidemia using N-substituted

1988-10-31

1990-08-07

Lee, Mary C.

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C07C10330

Patent

active

049469630

ABSTRACT:
An isoxazolidin-3,5-dione for the control of hyperlipidemia in mammals having the following structural formula: ##STR1## wherein R.sup.1 and R.sup.2 are each an alkyl of 1 to 4 carbons; R.sup.3 is an alkoxybenzoyl group containing from 1 to 3 alkoxy groups wherein the alkoxy groups have from 1 to 4 carbon atoms, an alkoxybenzoyl group wherein the alkyl group had from 1 to 4 carbons, a halobenzoyl group, or a group ##STR2## where together R.sup.10 and R.sup.11 form a C.sub.3 to C.sub.7 alkylene group, and R.sup.12 and R.sup.13 are each alkyl from 1 to 4 carbon atoms.

REFERENCES:
patent: 3007936 (1961-11-01), Matter et al.
patent: 4256819 (1977-07-01), Kodak
patent: 4302238 (1981-11-01), Konz
patent: 4351844 (1982-09-01), Patchett et al.
patent: 4395417 (1983-07-01), Hall et al.
patent: 4499303 (1985-02-01), Wyrick et al.
patent: 4504486 (1985-03-01), Kurkov
patent: 4639444 (1987-01-01), Fujikawa et al.
patent: 4681893 (1987-07-01), Roth
Manik Lal Debnath-"The Reaction of Benzohydroxamine . . ." 1985 Master's Thesis.
Derwent 85-080808 3/12/85 Chevron Research Co.
Manik Lak Debnath-Master's Thesis-"The Reaction of Benzohydroxamic Acids With Dicarboxylic Acid Chlorides in the Synthesis of 2,3-Benzoxazine-1,4-Diones and Isozaxzolidine-3,5-Diones" (1985).
Ronda Gayle Davis-Master's Thesis-"The Reaction of Acetone Oxime with Dicarboxylic Acid Chlorides in the Synthesis of Isoxazolidine-3, 5-Diones and 2,3-Benzoxazine-1,4-Diones" (1983).
Robert A. Izydore, Samuel McLean-Dept. of Chemistry, North Carolina Central University-Reprinted from the American Chemical Society, 97,5611(1975) "1,2-Addition Reaction of Ethyl Diazoacetate and 4-Phenyl-1,2,4-Triazoline-3,5-Dione".
Michel K. et al., Helv Chim Acta 48 (8) 1973-83 1965 CA64:12657c-h.
Rehse K., Meder J., Arch Pharm 319 (2) 133-40 1986 CA105:6446 h.
Zinner G; et al., Arch Pharm 299 (3) 222-51966 CA 64:19597d.
Zinner G. and Moll R., Arch Pharm 299 (6)562-8 1966 CA 65:10575g-h.
Ans. 40-CA 65:10575h, 1966.
Ans. 45-CA 78 (25):159531f, 1973.
Ans. 46-48-CA78(25):159531f, 1973.
Ans. 50-51-CA80(15):82760m, 1974.
Ans. 54,56-58,61,65-66-CA80(15):82760m, 1974.
Ans. 67 (1) CA1.theta.4(22):186891k, 1986 (2) CA99(16):122993r, 1982.
(3) CA97(22):182935s 1982 and (4) CA87(10):68722p, 1977.
Ans. 68-CA92(21):181038m, 1980.
Ans. 72-CA93(15):149273u, 1980.
Ans. 74-77, 79-80-CA96(25):217824p, 1981.
Ans. 83 CA105(1):6446h, 1986.
Arch. Pharm. (Weiheim) 319, 133-140 (1986). Anticoagulante.

Affiliated with

Also associated with

Rating

Compounds for the control of hyperlipidemia using N-substituted does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds for the control of hyperlipidemia using N-substituted , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for the control of hyperlipidemia using N-substituted will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-961571